1st Circ. Wonders Why FDA Should Not Decide Eyedrop Suit
The First Circuit on Monday questioned both sides in a suit involving a group of pharmaceutical companies — including Allergan, Bausch and Lomb, Merck and Pfizer — and a putative class...To view the full article, register now.
Already a subscriber? Click here to view full article